Many diseases, including cancer, are dependent on the growth of new blood v
essels, a process known as angiogenesis, Differences in an individual's abi
lity to grow new blood vessels may influence the rate of progression of the
se diseases. Here we show that different strains of inbred mice have an sim
ilar to 10-fold range of response to growth factor-stimulated angiogenesis
in the corneal micropocket assay. The in vitro migratory activity of endoth
elial cells from aortic rings of selected strains correlated with the in vi
vo responsiveness. Further, a differential sensitivity to angiogenesis inhi
bitors was seen between strains, with one strain demonstrating resistance t
o both TNP-470 and thalidomide. These results suggest the presence of genet
ic factors that control individual angiogenic potential.